Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study

Cardiovasc DiabetolPublished Longitudinal cohort study

Authors' conclusion

The relationship between HOMA-IR and all-cause mortality was U-shaped in patients with CHD and hypertension. HOMA-IR was a reliable predictor of all-cause mortality in this population.

Study context

Population
Patients with coronary heart disease and hypertension, NHANES 2001–2018455 died
Participants
1,126 patients
Exposure
Homeostatic model assessment of IR (HOMA-IR) below vs above inflection point 3.59
Outcome
All-cause mortality
Follow-up
Median 76 months
Methodological detailsNHANES 2001-2018 linked to National Death Index, multivariate Cox regression, restricted cubic splines
  • NHANES 2001-2018 linked to National Death Index
  • Multivariate Cox regression
  • Restricted cubic splines

Main finding

As reported in the abstract

All-cause mortality by HOMA-IR (segmented effect; inflection point 3.59)

RCS showed HOMA-IR had a segmented effect on all-cause mortality; inflection point (statistically significant)

3.59

Observational data: associations, not effects.

Further findings

Prediction of survival status by HOMA-IR (ROC and calibration curves)

AUC
0,812

Interactions with stratified variables (age, gender, diabetes, cancer, hypoglycemic and lipid-lowering drug use)

No interactions between HOMA-IR and stratified variables were found

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Association between different insulin resistance surrogates and all-cause mortality in patients with coronary heart disease and hypertension: NHANES longitudinal cohort study. Cardiovasc Diabetol. Published 28 February 2024. doi:10.1186/s12933-024-02173-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.